Latest Options News

RocketBoots Limited has successfully converted its AI-powered retail banking trial into a contract rollout with a major Australian bank, marking a significant step in its commercial expansion.

Dimerix Limited’s ACTION3 Phase 3 trial for DMX-200 in FSGS kidney disease has passed its seventh Independent Data Monitoring Committee review with no safety concerns, reinforcing the drug’s promising safety profile.

Prescient Therapeutics has achieved a key regulatory milestone with the European Medicines Agency granting Orphan Drug Designation for its PTX-100 therapy targeting Cutaneous T-cell Lymphomas, enhancing its commercial and clinical prospects in Europe.

Middle Island Resources has identified significant lead and zinc soil anomalies at the Tisovik target within its Bobija Project in Serbia, highlighting promising exploration potential in a historically mined area. Assay results reveal high-grade mineralisation footprints extending over 1.5km, setting the stage for further investigation.

Tungsten Mining NL’s latest scoping study for the Mt Mulgine Project in Western Australia reveals a robust critical minerals asset with strong financial metrics and a clear path to production by 2029.

DevEx Resources has appointed Marnie Finlayson, a seasoned mining executive from Rio Tinto, as Managing Director starting December 2025, signaling a strategic push in uranium and rare earth projects.

Sheffield Resources announces a $6.5 million contribution to support the Thunderbird Mineral Sands Mine as Kimberley Mineral Sands navigates ongoing debt restructuring discussions with lenders.

Rent.com.au has seen option holders exercise over $4 million early, injecting significant growth capital and accelerating its path to profitability.

Andromeda Metals has raised nearly $1 million through a Share Purchase Plan, bringing total recent capital to almost $14 million to advance its Great White and HPA projects.

Li-S Energy has accelerated its transition from research to manufacturing with a $7.8 million ARENA grant, new commercial partnerships, and plans for a large-scale production facility.

Biotron Limited has launched a $1.5 million non-renounceable rights issue to fund its strategic acquisition of Sedarex Limited and support ongoing drug development programs. The capital raise follows shareholder approval and aims to diversify Biotron’s portfolio with a next-generation general anaesthetic.

Forrestania Resources has signed a binding agreement to acquire the Lake Johnston Project, including a 1.5Mtpa processing plant, supported by a $34 million capital raise. This acquisition marks a pivotal step towards near-term gold production and a strategic shift from exploration to development.